Pharmaceutical Supply – Cephalexin Capsules

The contract awards the supply of FDA-approved Cephalexin Capsules, 250 mg strength, in compliance with National Stock Number 6505017240531, to meet the stringent quality and logistical requirements of the Department of Defense. The product must conform to United States Pharmacopeia standards and be packaged in bulk tube formats suitable for military distribution and storage. The supplier is expected to adhere to Defense Logistics Agency protocols, ensuring consistency, traceability, and readiness for deployment across military medical systems. This subcontract, issued under NAICS code 325412 for pharmaceutical and botanical product manufacturing, is managed by the Defense Logistics Agency under the Department of Defense. The solicitation was posted on July 14, 2026, and the award is linked to contract SPE2DX25D9900 with delivery order SPE2DP26F7564, specifying a quantity of 7,056 units. Performance is bound by DoD logistics standards, requiring strict adherence to packaging, labeling, and delivery timelines to support military healthcare operations. Although specific performance location details are not provided, procurement is intended for nationwide defense medical supply chain integration.